Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  392 results for ""Double-Blind Method""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Risankizumab Induction Therapy Achieves Early Symptom Improvements That Are Associated With Future Clinical and Endoscopic Outcomes in Crohn's Disease: Post Hoc Analysis of the ADVANCE, MOTIVATE, and FORTIFY Phase 3 Studies.

  • Authors : Colombel JF; The Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Schreiber S

Subjects: Crohn Disease*/Crohn Disease*/Crohn Disease*/drug therapy ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/therapeutic use ; Antibodies, Monoclonal*/Antibodies, Monoclonal*/Antibodies, Monoclonal*/administration & dosage

  • Source: Journal of Crohn's & colitis [J Crohns Colitis] 2024 Jun 03; Vol. 18 (6), pp. 818-827.Publisher: Oxford University Press Country of Publication: England NLM ID: 101318676 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Impact of Concomitant Thiopurine on the Efficacy and Safety of Filgotinib in Patients with Ulcerative Colitis: Post Hoc Analysis of the Phase 2b/3 SELECTION Study.

  • Authors : Watanabe K; Department of Internal Medicine for Inflammatory Bowel Disease, University of Toyama, Toyama, Japan.; Peyrin-Biroulet L

Subjects: Colitis, Ulcerative*/Colitis, Ulcerative*/Colitis, Ulcerative*/drug therapy ; Drug Therapy, Combination*; Humans

  • Source: Journal of Crohn's & colitis [J Crohns Colitis] 2024 Jun 03; Vol. 18 (6), pp. 801-811.Publisher: Oxford University Press Country of Publication: England NLM ID: 101318676 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Efficacy and Safety of Filgotinib for the Treatment of Perianal Fistulising Crohn's Disease [DIVERGENCE 2]: A Phase 2, Randomised, Placebo-controlled Trial.

  • Authors : Reinisch W; Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.; Colombel JF

Subjects: Crohn Disease*/Crohn Disease*/Crohn Disease*/complications ; Crohn Disease*/Crohn Disease*/Crohn Disease*/drug therapy ; Rectal Fistula*/Rectal Fistula*/Rectal Fistula*/etiology

  • Source: Journal of Crohn's & colitis [J Crohns Colitis] 2024 Jun 03; Vol. 18 (6), pp. 864-874.Publisher: Oxford University Press Country of Publication: England NLM ID: 101318676 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme.

  • Authors : Raine T; Department of Gastroenterology, Addenbrooke's Hospital, Cambridge University Hospitals, Cambridge, UK.; Ishiguro Y

Subjects: Colitis, Ulcerative*/Colitis, Ulcerative*/Colitis, Ulcerative*/drug therapy ; Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/therapeutic use ; Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/Heterocyclic Compounds, 3-Ring*/adverse effects

  • Source: Journal of Crohn's & colitis [J Crohns Colitis] 2024 May 31; Vol. 18 (5), pp. 695-707.Publisher: Oxford University Press Country of Publication: England NLM ID: 101318676 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

The Safety, Tolerability, Pharmacokinetics, and Clinical Efficacy of the NLRX1 agonist NX-13 in Active Ulcerative Colitis: Results of a Phase 1b Study.

  • Authors : Verstockt B; Department of Gastroenterology and Hepatology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.; Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium.

Subjects: Colitis, Ulcerative*/Colitis, Ulcerative*/Colitis, Ulcerative*/drug therapy; Humans ; Male

  • Source: Journal of Crohn's & colitis [J Crohns Colitis] 2024 May 31; Vol. 18 (5), pp. 762-772.Publisher: Oxford University Press Country of Publication: England NLM ID: 101318676 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Therapeutic high-dose vitamin D for vitamin D-deficient severe COVID-19 disease: randomized, double-blind, placebo-controlled study (SHADE-S).

  • Authors : Singh A; Department of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research, Chandigarh, India.; Rastogi A

Subjects: COVID-19*/COVID-19*/COVID-19*/mortality ; COVID-19*/COVID-19*/COVID-19*/complications ; Vitamin D Deficiency*/Vitamin D Deficiency*/Vitamin D Deficiency*/drug therapy

  • Source: Journal of public health (Oxford, England) [J Public Health (Oxf)] 2024 May 29; Vol. 46 (2), pp. 256-266.Publisher: Oxford University Press Country of Publication: England NLM ID: 101188638 Publication Model: Print Cited Medium:

Record details

×
Academic Journal

Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy).

  • Authors : Scullion KM; Centre for Cardiovascular Science, University of Edinburgh, Queen's Medical Research Institute, Edinburgh EH16 4TJ, UK.; MacIntyre IM

Subjects: Acetaminophen* ; Cross-Over Studies* ; Alanine Transaminase*/Alanine Transaminase*/Alanine Transaminase*/blood

  • Source: Toxicological sciences : an official journal of the Society of Toxicology [Toxicol Sci] 2024 May 28; Vol. 199 (2), pp. 203-209.Publisher: Oxford University Press Country of Publication: United States NLM ID: 9805461 Publication Model: Print Cited

Record details

×
  • 1-10 of  392 results for ""Double-Blind Method""